Prevalence of microalbuminuria in recently diagnosed Type 2 diabetes mellitus and its relationship to non-traditional risk factors: observations from the ADOPT study

Documenti analoghi

• Levels of beta-cell dysfunction and insulin resistance differ between Europeans and North Americans with recently-diagnosed diabetes in the ADOPT study
  di: Holman, R, et al.
  Pubblicazione: (2003)
• A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes.
  di: Viberti, G, et al.
  Pubblicazione: (2002)
• A Diabetes Outcome Progression Trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes
  di: Viberti, G, et al.
  Pubblicazione: (2002)
• ADOPT: The effectiveness of metformin versus glyburide in type 2 diabetes
  di: Herman, W, et al.
  Pubblicazione: (2007)
• Determinants of monotherapy failure in ADOPT - (A diabetes outcome progression trial)
  di: Holman, R, et al.
  Pubblicazione: (2007)